• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Bigfoot Biomedical adds former Insulet VP as chief commercial officer

May 26, 2022 By Sean Whooley

Bigfoot Biomedical smart insulin pen cap
Bigfoot Biomedical smart insulin pen cap [Image from Bigfoot Biomedical]
Bigfoot Biomedical announced today that it appointed former Insulet executive Matt Rainville as its chief commercial officer.

Rainville’s role includes leading the growth of Milpitas, California–based Bigfoot Biomedical’s fully commercial Bigfoot Unity diabetes management program as the company looks to expand access to its offerings.

Bigfoot Unity aims to simplify CGMs and the data they produce to tell people how much insulin to take at a given point in time. It’s comprised of a smart insulin pen cap, which takes data from a CGM and informs the patient of exactly how much insulin they need.

The company has partnered with Abbott and the FreeStyle Libre 2 CGM sensor that integrates into its system, with the pen caps “talking” to the FreeStyle Libre as part of the all-encompassing design of Bigfoot Unity.

Read: How Bigfoot Biomedical plans to take diabetes management forward

Matt Rainville, Bigfoot Biomedical's new chief commercial officer
Matt Rainville, Bigfoot Biomedical’s new chief commercial officer [Image from Rainville’s LinkedIn page]
Rainville joins the company having previously served as VP and GM of global type 2 markets at Insulet. He led Insulet’s Omnipod type 2 franchise and helped expand access to insulin pumps for people with diabetes.

Before Insulet, Rainville held a number of roles across 13 years at Eli Lilly. Among those positions included leadership spots in sales, training and development, marketing, operations and market access. He contributed to the successful launch of nine diabetes products globally at Eli Lilly, according to a news release.

“Hiring a chief commercial officer is a crucial step for our business as we expand access to our Bigfoot Unity system and further develop our pipeline,” Bigfoot Biomedical CEO Jeffrey Brewer said in the release. “Matt has a proven track record developing effective commercial and market access strategies that have driven adoption of technologies for people with diabetes. His experience will serve us well as we continue to grow our presence in the commercial marketplace. We are thrilled to welcome Matt to the Bigfoot leadership team and are eager to harness his passion for improving care for people with diabetes.”

Rainville represents the latest personnel addition as Bigfoot expands its leadership team, with the company hiring a trio of executives with experience in the diabetes and healthcare sectors in December 2021.

“I’m honored to accept this role at a watershed moment for Bigfoot, as we build momentum and work to transform the management of multiple daily injections (MDI) of insulin,” Rainville said. “We have a differentiated product, a skilled team and a community of patients who need solutions for insulin management. My focus is on expanding access to these solutions for people on MDI therapy.”

Filed Under: Auto-injectors, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Bigfoot Biomedical, Personnel, Personnel Moves

IN CASE YOU MISSED IT

  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS